New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
16:05 EDTMYGNMyriad Genetics to acquire Crescendo Bioscience for $270M cash
Myriad Genetics announced that it has entered into a definitive agreement to acquire Crescendo Bioscience for $270M in cash which will be reduced by $25M for the repayment of a loan made to Crescendo and customary adjustments in accordance with the acquisition agreement.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MYGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use